Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study

被引:28
作者
Dulskas, Audrius [1 ,2 ]
Gaizauskas, Vytautas [3 ]
Kildusiene, Inga [4 ]
Samalavicius, Narimantas Evaldas [2 ,5 ,6 ]
Smailyte, Giedre [4 ,7 ]
机构
[1] Natl Canc Inst, Dept Abdominal & Gen Surg & Oncol, 1 Santariskiu Str, LT-08406 Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Inst Clin Med, LT-03101 Vilnius, Lithuania
[3] Vilnius Univ Hosp, Dept Abdominal Surg, Santaros Clin, 2 Santariskiu Str, LT-08661 Vilnius, Lithuania
[4] Natl Canc Inst, Lab Canc Epidemiol, LT-08406 Vilnius, Lithuania
[5] Klaipeda Univ Hosp, Dept Surg, 41 Liepojos Str, LT-92288 Klaipeda, Lithuania
[6] Klaipeda Univ, Hlth Res & Innovat Sci Ctr, Fac Hlth Sci, 84 Herkaus Manto Str, LT-92294 Klaipeda, Lithuania
[7] Vilnius Univ, Fac Med, Inst Hlth Sci, LT-03101 Vilnius, Lithuania
关键词
colorectal cancer; colorectal cancer survival; national burden; Lithuanian cancer registry; III COLON-CANCER; STAGE-II; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; EXCISION; TRENDS;
D O I
10.3390/jcm9124038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included. We examined the changes in colorectal cancer mortality and survival rates between 1998 and 2012 according to cancer anatomical sub-sites and stages. We calculated the 5-year relative survival estimates using period analysis. Results: Overall, 20,980 colorectal cancer cases reported from 1998 to 2012 were included in the study. The total number of newly diagnosed colorectal cancers increased from 1998-2002 to 2008-2012 by 12.1%. The highest number of colorectal cancers was localized and increased from 33.9% to 42.0%. The number of cancers with regional metastases and advanced cancers decreased by 11.1% and 15.5%, respectively. An increased number of new cases was observed for almost all colon cancer sub-sites. The overall 5-year relative survival rate increased from 37.9% in 1998-2002 to 51.5% in 2008-2012. We showed an increase in survival rates for all stages and all sub-sites. In the most recent period, patients with a localized disease had a 5-year survival rate of 78.6%, while survival estimates for advanced cancer patients remained low at 6.6%. Conclusion: Although survival rates variated in colorectal cancer patients according to disease stages and sub-sites, we showed increased survival rates for all patients.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) [J].
Allemani, Claudia ;
Weir, Hannah K. ;
Carreira, Helena ;
Harewood, Rhea ;
Spika, Devon ;
Wang, Xiao-Si ;
Bannon, Finian ;
Ahn, Jane V. ;
Johnson, Christopher J. ;
Bonaventure, Audrey ;
Marcos-Gragera, Rafael ;
Stiller, Charles ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Ogunbiyi, Olufemi J. ;
Rachet, Bernard ;
Soeberg, Matthew J. ;
You, Hui ;
Matsuda, Tomohiro ;
Bielska-Lasota, Magdalena ;
Storm, Hans ;
Tucker, Thomas C. ;
Coleman, Michel P. .
LANCET, 2015, 385 (9972) :977-1010
[2]  
American Cancer Society, SURV RAT COL CANC
[3]   Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study [J].
Andre, Thierry ;
de Gramont, Armand ;
Vernerey, Dewi ;
Chibaudel, Benoist ;
Bonnetain, Franck ;
Tijeras-Raballand, Annemilai ;
Scriva, Aurelie ;
Hickish, Tamas ;
Tabernero, Josep ;
Van Laethem, Jean Luc ;
Banzi, Maria ;
Maartense, Eduard ;
Shmueli, Einat ;
Carlsson, Goran U. ;
Scheithauer, Werner ;
Papamichael, Demetris ;
Moeehler, Marcus ;
Landolfi, Stefania ;
Demetter, Pieter ;
Colote, Soudhir ;
Tournigand, Christophe ;
Louvet, Christophe ;
Duval, Alex ;
Flejou, Jean-Francois ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) :4176-+
[4]   Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].
Andre, Thierry ;
Boni, Corrado ;
Navarro, Matilde ;
Tabernero, Josep ;
Hickish, Tamas ;
Topham, Clare ;
Bonetti, Andrea ;
Clingan, Philip ;
Bridgewater, John ;
Rivera, Fernando ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116
[5]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[6]   Comparative cancer survival information in Europe [J].
Berrino, Franco ;
Verdecchia, Arduino ;
Lutz, Jean Michel ;
Lombardo, Claudio ;
Micheli, Andrea ;
Capocaccia, Riccardo .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (06) :901-908
[7]  
Bierley JD., 2017, UICC TNM Classification of Malignant Tumours. Digestive System Tumours, V8th
[8]   Volume-outcome analysis of colorectal cancer-related outcomes [J].
Borowski, D. W. ;
Bradburn, D. M. ;
Mills, S. J. ;
Bharathan, B. ;
Wilson, R. G. ;
Ratcliffe, A. A. ;
Kelly, S. B. .
BRITISH JOURNAL OF SURGERY, 2010, 97 (09) :1416-1430
[9]   Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer [J].
Braendengen, Morten ;
Tveit, Kjell M. ;
Berglund, Ake ;
Birkemeyer, Elke ;
Frykholm, Gunilla ;
Pahlman, Lars ;
Wiig, Johan N. ;
Bystrom, Per ;
Bujko, Krzysztof ;
Glimelius, Bengt .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3687-3694
[10]   Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration [J].
Bray, F. ;
Ferlay, J. ;
Laversanne, M. ;
Brewster, D. H. ;
Mbalawa, C. Gombe ;
Kohler, B. ;
Pineros, M. ;
Steliarova-Foucher, E. ;
Swaminathan, R. ;
Antoni, S. ;
Soerjomataram, I. ;
Forman, D. .
INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (09) :2060-2071